SEC Form 4 · accession 0001193125-26-331690
CHEMED CORP · CHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J McNamara
Officer — president and CEO · Director
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 9:24 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000019584
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Capital Stock | Jul 31, 2026 | M | 2,001 | $445.35 | A | 92,220 | D | |
| Capital Stock | Jul 31, 2026 | F | 19,802 | $529.22 | D | 72,418 | D | |
| Capital StockF2 | Aug 3, 2026 | S | 2,000 | $539.51 | D | 70,418 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy with tandem tax withholding)F3 | $445.35 | Aug 3, 2026 | M | 2,001 | D | — | Oct 28, 2026 | Capital Stock | 2,001 | 264,158 | D |
Explanation of responses
- F1Payment of purchase price and tax obligation on stock option exercise.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.59 to $543.50. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.
- F3Vesting in three equal annual installments commencing 10/28/2022.